이새별
#수술후 퇴원클리닉#유방암클리닉#유방질환
|
학력
2013 .03 ~ 2015 .02울산대학교 의학 박사
2011 .03 ~ 2013 .02울산대학교 의학 석사
2001 .03 ~ 2007 .02건양대학교 의학 학사
2011 .03 ~ 2013 .02울산대학교 의학 석사
2001 .03 ~ 2007 .02건양대학교 의학 학사
경력
2019 .03 ~ 현재서울아산병원 유방외과 조교수
2016 .03 ~ 2019 .02서울아산병원 유방외과 임상전임강사
2014 .09Visiting doctor, University of Melbourne School of Population and Global Health
2013 .03 ~ 2016 .02서울아산병원 유방외과 임상강사(전임의, 펠로우)
2011 .10Visiting doctor, Dana-Farber/Brigham and Women’s Cancer Center
2009 .03 ~ 2013 .03서울아산병원 외과 전공의(레지던트)
2008 .03 ~ 2009 .02서울아산병원 수련의(인턴)
2016 .03 ~ 2019 .02서울아산병원 유방외과 임상전임강사
2014 .09Visiting doctor, University of Melbourne School of Population and Global Health
2013 .03 ~ 2016 .02서울아산병원 유방외과 임상강사(전임의, 펠로우)
2011 .10Visiting doctor, Dana-Farber/Brigham and Women’s Cancer Center
2009 .03 ~ 2013 .03서울아산병원 외과 전공의(레지던트)
2008 .03 ~ 2009 .02서울아산병원 수련의(인턴)
논문
Survival outcome of adjuvant endocrine therapy alone for patients with lymph node-positive, hormone-responsive, HER2-negative breast cancer.
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor?Positive, Human Epidermal Growth Factor 2 (HER2)?Negative Breast Cancer.
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts.
Chronological Improvement in Survival of Patients with Breast Cancer: A Large-Scale, Single-Center Study.
Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.
Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.
Long-term outcomes of patients with breast cancer after nipple-sparing mastectomy/skin-sparing mastectomy followed by immediate transverse rectus abdominis musculocutaneous flap reconstruction: Comparison with conventional mastectomy in a single center study.
Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
Oncologic safety of skin-sparing mastectomy followed by immediate reconstruction in young patients with breast cancer.
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
Uneven recovery patterns of compromised health-related quality of life (EQ-5D-3 L) domains for breast Cancer survivors: a comparative study.
Association between patient beliefs about endocrine therapy and medication adherence in Korean breast cancer survivors
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor?Positive, Human Epidermal Growth Factor 2 (HER2)?Negative Breast Cancer.
A retrospective prognostic evaluation analysis using the 8th edition of the American Joint Committee on Cancer staging system for breast cancer.
Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women.
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts.
Chronological Improvement in Survival of Patients with Breast Cancer: A Large-Scale, Single-Center Study.
Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.
Comparative Study between Sentinel Lymph Node Biopsy and Axillary Dissection in Patients with One or Two Lymph Node Metastases
Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.
Long-term outcomes of patients with breast cancer after nipple-sparing mastectomy/skin-sparing mastectomy followed by immediate transverse rectus abdominis musculocutaneous flap reconstruction: Comparison with conventional mastectomy in a single center study.
Neoadjuvant Chemotherapy and Prognosis of Pregnancy-Associated Breast Cancer: A Time-Trends Study of the Korean Breast Cancer Registry Database
No Association of Positive Superficial and/or Deep Margins with Local Recurrence in Invasive Breast Cancer Treated with Breast-Conserving Surgery.
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model.
Oncologic safety of skin-sparing mastectomy followed by immediate reconstruction in young patients with breast cancer.
Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer with axillary node metastasis: A survey of clinical practice.
Survival analysis according to period and analysis of the factors influencing changes in survival in patients with recurrent breast cancer: a large-scale, single-center study.
Uneven recovery patterns of compromised health-related quality of life (EQ-5D-3 L) domains for breast Cancer survivors: a comparative study.
Association between patient beliefs about endocrine therapy and medication adherence in Korean breast cancer survivors
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
A prospective observational study protocol for developing distress management algorithms using mobile device based health logs in breast cancer survivors
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
Analysis of serial circulating tumor cell count during neoadjuvant systemic therapy in breast cancer patients
The patient underwent axillary lymph node dissection was treated with a mixture of Poloxamer and Alginate (Guardix-SG®) Impact on range of action: Single-institution, prospective, randomized, double-blind investigator pilot study
A prospective observational study protocol for developing distress management algorithms using mobile device based health logs in breast cancer survivors
Clinicopathologic Characteristics and Prognostic factors of pure mucinous breast cancer
Screening for Psychological Distress in Breast Cancer Patients and Psychiatric Referral acceptance among Screen Positive Patients
Evaluation of Surgical Guides Using a 3D Printer in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
A Nomogram for Predicting the Oncotype DX Recurrence Score in Women with T1-3N0-1miM0 Hormone Receptor-positive, Human Epidermal Growth Factor-2 (HER2)-negative Breast Cancer
No negative effect of short-term delays in surgery on tumor progression and survival outcomes in invasive breast cancer.
CHEMOTHERAPY FOR NODE-NEGATIVE, HORMONE RECEPTOR-POSITIVE MUCINOUS CARCINOMA OF BREAST
Breast-specific gamma imaging versus magnetic resonance imaging in ductal carcinoma in situ: A prospective head-to-head trial
Poor survival of the young breast cancer is due to early and late recurrence in non triple negative breast cancer
Discordance of hormone receptor and human epidermal growth factor receptor2 as a prognostic factor of survival between primary breast cancer and recurrent breast cancer.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.